Accessibility Menu
 
Pro Medicus logo

Pro Medicus

(ASX) PME

Current Price$126.92
Market Cap$13.31B
Since IPO (2000)+15,690%
5 Year+182%
1 Year-38%
1 Month-7%

Pro Medicus Financials at a Glance

Market Cap

$13.31B

Revenue (TTM)

$425.15M

Net Income (TTM)

$332.98M

EPS (TTM)

$2.24

P/E Ratio

56.71

Dividend

$0.62

Beta (Volatility)

-0.01 (Low)

Price

$126.92

Volume

293,376

Open

$121.92

Previous Close

$126.92

Daily Range

$120.08 - $127.38

52-Week Range

$107.75 - $336.00

PME News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Pro Medicus

Industry

Health Care Technology

Employees

132

CEO

Sam Aaron Hupert, MD

Headquarters

Richmond, VIC 3121, AU

PME Financials

Key Financial Metrics (TTM)

Gross Margin

78%

Operating Margin

74%

Net Income Margin

98%

Return on Equity

77%

Return on Capital

37%

Return on Assets

44%

Earnings Yield

1.76%

Dividend Yield

0.00%

Payout Ratio

24.49%

Stock Overview

Market Cap

$13.31B

Shares Outstanding

104.47M

Volume

293.38K

Short Interest

0.00%

Avg. Volume

487.51K

Financials (TTM)

Gross Profit

$212.60M

Operating Income

$157.61M

EBITDA

$164.85M

Operating Cash Flow

$111.33M

Capital Expenditure

$7.38M

Free Cash Flow

$103.95M

Cash & ST Invst.

$209.19M

Total Debt

$2.25M

Pro Medicus Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$124.78M

+68.4%

Gross Profit

$96.16M

+76.1%

Gross Margin

77.07%

N/A

Market Cap

$13.31B

N/A

Market Cap/Employee

$168.45M

N/A

Employees

79

N/A

Net Income

$171.22M

+372.3%

EBITDA

$94.31M

+72.8%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Net Cash

$219.26M

+67.4%

Accounts Receivable

$77.90M

+83.4%

Inventory

$85.00K

+25.0%

Long Term Debt

$3.56M

+80.0%

Short Term Debt

$768.00K

+37.9%

Return on Assets

43.96%

N/A

Return on Invested Capital

36.81%

N/A

Free Cash Flow

$69.13M

+150.1%

Operating Cash Flow

$69.39M

+122.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
COH.AXCochlear Limited
$172.10-0.77%
FPH.AXFisher & Paykel Healthcare Corporation Limited
$32.02-0.28%
CGS.AXCogstate Limited
$2.30+3.14%
ALC.AXAlcidion Group Limited
$0.10+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$10.45+0.02%
TQQQProShares Trust - ProShares UltraPro Qqq
$48.96+0.02%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$67.86-0.02%
NIONio
$6.07-0.05%

Questions About PME

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.